Trending Now
Software & Data
AI Company InstaDeep to Be Acquired by BioNTech for Nearly $700...
German biotechnology company BioNTech recently announced that it will fully acquire artificial intelligence (AI) provider InstaDeep in a deal worth about £562 million ($685.9 million) to aid in the discovery of new drugs. This includes about £362m in cash for shares as yet unowned by BioNTech and up to £200m in future performance-based milestone payments.
Medical Devices
ResMed to Bring New Manufacturing Facility Online to Meet CPAP Demand,...
San Diego, California-based medical equipment company ResMed recently announced that it is bringing a new manufacturing facility online to meet demand for sleep apnea devices. ResMed is the largest manufacturer of CPAP and bilevel positive airway pressure devices by market share...
Consumer Internet
Smartphones: The New Doctor’s Office?
Although using smartphones as diagnostic tools is a work in progress, doctors and patients have found some real-world success in employing phones as medical devices. For instance, in the Google Fit app, users can check their heart rate by placing their finger on the rear-facing camera lens or track their breathing rate using the front-facing camera...
Biotech
IRA Pushes Drug Companies to Favor Biotech Meds Over Pills
Due to recent U.S. legislation which gives biologics a longer runway before becoming subject to government price limits, drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills. Such a shift in focus could result in the availability of far fewer cheap, generic pills in the long run...
Features
Possibilities for RNA Therapies Seemingly Limitless
Thanks to the COVID-19 vaccines, messenger RNA (mRNA) went from "a technology looking for a disease" to a global phenomenon in the last few years, and it could soon find its way into treatments for cancer, heart conditions, and more. “Before COVID and the vaccines, there were a handful of biotech companies doing RNA work,” said Drew Weissman...